Transferrin functionalization enhances prostate cancer cell uptake and cytotoxicity of cabazitaxel-loaded polymeric nanoparticles.
Prostate cancer (PCa) is the second most common cancer in men worldwide, and chemotherapeutic treatment may exhibit limited efficacy owing to side effects and hypersensitivity. Cabazitaxel (CTX) is an antineoplastic agent used to treat prostate cancer; however, it has low selectivity and adverse effects that limit its...